심장 발작 진단 시장 : 유형별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Heart Attack Diagnostics Market By Type (Electrocardiogram, Blood Tests, Angiogram, Computerized Cardiac Tomography, Others), By End User (Hospitals, Diagnostics Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,094,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,207,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

심장 발작 진단 시장

심장 발작 진단 시장은 2023년 92억 달러로 평가되며, 2024-2033년 연평균 8.6% 성장하여 2033년에는 211억 달러에 달할 것으로 예상됩니다.

심장 발작 진단은 환자의 혈압, 체온, 맥박수를 진단하는 것으로 이루어집니다. 심근경색이라고도 하는 심장 발작이 발생했는지 여부를 판단하기 위해 일련의 평가가 이루어집니다. 일련의 진단 검사에는 심장의 전기적 활동을 측정하는 심전도(EKG), 심근이 손상되었을 때 혈액으로 방출되는 트로포닌과 같은 심근 효소를 검출하기 위한 혈액 검사, 심장과 혈관을 시각화하기 위한 관상동맥 조영술 및 심초음파 검사와 같은 영상 검사가 포함됩니다.

좌식 생활습관의 증가로 인해 심장마비를 포함한 생활습관병이 급증하고 있습니다. 이로 인해 심장 발작 진단에 대한 수요가 급증하면서 시장 성장을 가속화하고 있습니다. 또한, 전 세계 노인 인구의 급격한 증가는 시장 확대의 길을 열어주고 있습니다. 심전도 검사에 AI를 도입하는 것은 진단 시간을 단축할 수 있기 때문에 향후 주류가 될 수 있습니다. 대만의 한 병원은 AI와 심전도 동화에 대한 연구를 실시하여 진단 시간을 10분 단축했으며, AI의 끊임없는 개선은 임상 판단 지원 시스템의 효율성을 높이고 의료진이 이 기술을 채택하도록 장려하고 있습니다.

그러나 이러한 진단 테스트는 매우 고가이기 때문에 최종사용자가 그 이점을 활용하지 못해 시장 개척을 억제하고 있습니다. 또한, 새로운 진단 기술의 도입에는 다양한 규제 장벽이 있어 시장 확대에 걸림돌이 되고 있습니다. 미국 식품의약국, 유럽의약품청, 일본 의약품의료기기종합기구, 인도 중앙의약품표준관리기구 등 다양한 규제 기관은 새로운 진단 기술의 시장 진입에 대해 각각의 규제 가이드라인을 준수할 것을 요구하고 있습니다. 반대로, 혁신적인 기술이 시장에 도입되고 있다는 것은 유망한 미래를 보여주는 지표입니다. 예를 들어, 독일 의료 기업 지멘스 헬티니어스(Siemens Healthineers)는 30분 이내에 심장마비를 감지할 수 있는 핸드헬드 기기를 발표했습니다. 이러한 기기의 출시로 인해 치료가 더 빨리 이루어지고 환자의 회복 가능성이 높아질 것으로 기대됩니다.

부문별 리뷰

심장 발작 진단 시장은 유형, 최종사용자, 지역으로 분류됩니다. 유형별로 시장은 심전도, 혈액 검사, 혈관 조영술, 컴퓨터 심장 단층 촬영, 기타로 나뉩니다. 최종사용자에 따라 병원, 진단 센터, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.

이 보고서는 사용자 정의가 가능합니다.

• 고객의 관심사에 따른 기업 프로파일 추가
• 기업 개요 확대 목록
• 과거 시장 데이터

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 심장 발작 진단 시장 : 유형별

• 시장 개요
• 심전도
• 혈액 시험
• 혈관조영
• 컴퓨터 심장 단층촬영
• 기타

제5장 심장 발작 진단 시장 : 최종사용자별

• 시장 개요
• 병원
• 진단 센터
• 기타

제6장 심장 발작 진단 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국의 심장 발작 진단 시장
  • 캐나다의 심장 발작 진단 시장
  • 멕시코의 심장 발작 진단 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스의 심장 발작 진단 시장
  • 독일의 심장 발작 진단 시장
  • 이탈리아의 심장 발작 진단 시장
  • 스페인의 심장 발작 진단 시장
  • 영국의 심장 발작 진단 시장
  • 기타 유럽의 심장 발작 진단 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국의 심장 발작 진단 시장
  • 일본의 심장 발작 진단 시장
  • 인도의 심장 발작 진단 시장
  • 한국의 심장 발작 진단 시장
  • 호주의 심장 발작 진단 시장
  • 기타 아시아태평양의 심장 발작 진단 시장
• 라틴아메리카, 중동 및 아프리카
  • 주요 시장 동향과 기회
  • 브라질의 심장 발작 진단 시장
  • 남아프리카공화국의 심장 발작 진단 시장
  • 사우디아라비아의 심장 발작 진단 시장
  • 기타 라틴아메리카, 중동 및 아프리카의 심장 발작 진단 시장

제7장 경쟁 상황

• 소개
• 주요 성공 전략
• 주요 10개 기업 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제8장 기업 개요

• Bionet Co., Ltd
• TOSHIBA CORPORATION
• Bio-Rad Laboratories Inc
• Life Sign LLC
• Schiller AG
• Beckman Coulter, Inc.
• GE Healthcare
• Hitachi Medical Systems
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories

ksm

영문 목차

영문목차

Heart Attack Diagnostics Market

The heart attack diagnostics market was valued at $9.2 billion in 2023 and is projected to reach $21.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.

Heart attack diagnostic comprises of diagnosing the blood pressure, temperature, and pulse rate of a patient. A series of evaluations are conducted to determine if an individual has experienced a heart attack, also known as myocardial infarction. The series of diagnostic tests includes an electrocardiogram (EKG) which measures the electrical activity of heart, blood tests to detect cardiac enzymes such as troponin which are released into the bloodstream in case of heart muscle damage, and imaging tests such as coronary angiography or echocardiography for the visualization of heart & its blood vessels.

Increase in sedentary lifestyles has led to surge in occurrence of lifestyle diseases, including heart attack. This has led to surge in demand for heart attack diagnostics, hence augmenting the growth of the market. Furthermore, exponential growth in the geriatric population globally is opening avenues for the expansion of the market. The assimilation of AI in the EKG testing is poised to become mainstream in the future as it reduces the diagnosis time. A hospital in Taiwan conducted research regarding the assimilation of AI and EKG, which reduced the diagnosis period by 10 minutes. Constant improvements in AI are enhancing the efficacy of clinical decision support system, encouraging medical practitioners to adopt the technology.

However, these diagnostics tests are extremely expensive and prevent several end users from leveraging their benefits, hence restraining the market development. In addition, the introduction of new diagnostic technologies is subject to various regulatory hurdles, hence presenting challenges for the expansion of the market. Different regulatory bodies such as the U.S. Food and Drug Administration, European Medicines Agency, the Pharmaceuticals and Medical Devices Agency in Japan, and Central Drugs Standard Control Organization in India have mandated the adherence to their respective regulatory guidelines for the entry of new diagnostic technologies into the market. Contrarily, innovative techniques being introduced into the market are an indicator of its promising future. For instance, Siemens Healthineers, a German healthcare company, has introduced a handheld device which claims to detect heart attack in less than 30 minutes. The launch of such devices is expected to quicken treatment delivery and increase the chances of recovery for patients in the future.

Segment Review

The heart attack diagnostics market is segmented into type, end user, and region. On the basis of type, the market is divided into electrocardiogram, blood tests, angiogram, computerized cardiac tomography, and others. By end user, it is classified into hospitals, diagnostics centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Competition Analysis

The major players operating in the global heart attack diagnostics market include Bionet Co., Ltd, TOSHIBA CORPORATION, Bio-Rad Laboratories Inc, Life Sign LLC, Schiller AG, Beckman Coulter,Inc., GE Healthcare, Hitachi Medical Systems, F. Hoffmann-La Roche Ltd., and Abbott Laboratories. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Additional company profiles with specific to client's interest
• Expanded list for Company Profiles
• Historic market data

Key Market Segments

By Type

• Electrocardiogram
• Blood Tests
• Angiogram
• Computerized Cardiac Tomography
• Others

By End User

• Hospitals
• Diagnostics Centers
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Bionet Co., Ltd
• TOSHIBA CORPORATION
• Bio-Rad Laboratories Inc
• Life Sign LLC
• Schiller AG
• Beckman Coulter,Inc.
• GE Healthcare
• Hitachi Medical Systems
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.5. Market Dynamics
  • 3.5.1. Drivers
  • 3.5.2. Restraints
  • 3.5.3. Opportunities

CHAPTER 4: HEART ATTACK DIAGNOSTICS MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Electrocardiogram
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Blood Tests
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Angiogram
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country
• 4.5. Computerized Cardiac Tomography
  • 4.5.1. Key Market Trends, Growth Factors and Opportunities
  • 4.5.2. Market Size and Forecast, By Region
  • 4.5.3. Market Share Analysis, By Country
• 4.6. Others
  • 4.6.1. Key Market Trends, Growth Factors and Opportunities
  • 4.6.2. Market Size and Forecast, By Region
  • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: HEART ATTACK DIAGNOSTICS MARKET, BY END USER

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By End User
• 5.2. Hospitals
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Diagnostics Centers
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Others
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: HEART ATTACK DIAGNOSTICS MARKET, BY REGION

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Region
• 6.2. North America
  • 6.2.1. Key Market Trends and Opportunities
  • 6.2.2. Market Size and Forecast, By Type
  • 6.2.3. Market Size and Forecast, By End User
  • 6.2.4. Market Size and Forecast, By Country
  • 6.2.5. U.S. Heart Attack Diagnostics Market
    • 6.2.5.1. Market Size and Forecast, By Type
    • 6.2.5.2. Market Size and Forecast, By End User
  • 6.2.6. Canada Heart Attack Diagnostics Market
    • 6.2.6.1. Market Size and Forecast, By Type
    • 6.2.6.2. Market Size and Forecast, By End User
  • 6.2.7. Mexico Heart Attack Diagnostics Market
    • 6.2.7.1. Market Size and Forecast, By Type
    • 6.2.7.2. Market Size and Forecast, By End User
• 6.3. Europe
  • 6.3.1. Key Market Trends and Opportunities
  • 6.3.2. Market Size and Forecast, By Type
  • 6.3.3. Market Size and Forecast, By End User
  • 6.3.4. Market Size and Forecast, By Country
  • 6.3.5. France Heart Attack Diagnostics Market
    • 6.3.5.1. Market Size and Forecast, By Type
    • 6.3.5.2. Market Size and Forecast, By End User
  • 6.3.6. Germany Heart Attack Diagnostics Market
    • 6.3.6.1. Market Size and Forecast, By Type
    • 6.3.6.2. Market Size and Forecast, By End User
  • 6.3.7. Italy Heart Attack Diagnostics Market
    • 6.3.7.1. Market Size and Forecast, By Type
    • 6.3.7.2. Market Size and Forecast, By End User
  • 6.3.8. Spain Heart Attack Diagnostics Market
    • 6.3.8.1. Market Size and Forecast, By Type
    • 6.3.8.2. Market Size and Forecast, By End User
  • 6.3.9. UK Heart Attack Diagnostics Market
    • 6.3.9.1. Market Size and Forecast, By Type
    • 6.3.9.2. Market Size and Forecast, By End User
  • 6.3.10. Rest of Europe Heart Attack Diagnostics Market
    • 6.3.10.1. Market Size and Forecast, By Type
    • 6.3.10.2. Market Size and Forecast, By End User
• 6.4. Asia-Pacific
  • 6.4.1. Key Market Trends and Opportunities
  • 6.4.2. Market Size and Forecast, By Type
  • 6.4.3. Market Size and Forecast, By End User
  • 6.4.4. Market Size and Forecast, By Country
  • 6.4.5. China Heart Attack Diagnostics Market
    • 6.4.5.1. Market Size and Forecast, By Type
    • 6.4.5.2. Market Size and Forecast, By End User
  • 6.4.6. Japan Heart Attack Diagnostics Market
    • 6.4.6.1. Market Size and Forecast, By Type
    • 6.4.6.2. Market Size and Forecast, By End User
  • 6.4.7. India Heart Attack Diagnostics Market
    • 6.4.7.1. Market Size and Forecast, By Type
    • 6.4.7.2. Market Size and Forecast, By End User
  • 6.4.8. South Korea Heart Attack Diagnostics Market
    • 6.4.8.1. Market Size and Forecast, By Type
    • 6.4.8.2. Market Size and Forecast, By End User
  • 6.4.9. Australia Heart Attack Diagnostics Market
    • 6.4.9.1. Market Size and Forecast, By Type
    • 6.4.9.2. Market Size and Forecast, By End User
  • 6.4.10. Rest of Asia-Pacific Heart Attack Diagnostics Market
    • 6.4.10.1. Market Size and Forecast, By Type
    • 6.4.10.2. Market Size and Forecast, By End User
• 6.5. LAMEA
  • 6.5.1. Key Market Trends and Opportunities
  • 6.5.2. Market Size and Forecast, By Type
  • 6.5.3. Market Size and Forecast, By End User
  • 6.5.4. Market Size and Forecast, By Country
  • 6.5.5. Brazil Heart Attack Diagnostics Market
    • 6.5.5.1. Market Size and Forecast, By Type
    • 6.5.5.2. Market Size and Forecast, By End User
  • 6.5.6. South Africa Heart Attack Diagnostics Market
    • 6.5.6.1. Market Size and Forecast, By Type
    • 6.5.6.2. Market Size and Forecast, By End User
  • 6.5.7. Saudi Arabia Heart Attack Diagnostics Market
    • 6.5.7.1. Market Size and Forecast, By Type
    • 6.5.7.2. Market Size and Forecast, By End User
  • 6.5.8. Rest of LAMEA Heart Attack Diagnostics Market
    • 6.5.8.1. Market Size and Forecast, By Type
    • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

• 7.1. Introduction
• 7.2. Top Winning Strategies
• 7.3. Product Mapping of Top 10 Player
• 7.4. Competitive Dashboard
• 7.5. Competitive Heatmap
• 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

• 8.1. Bionet Co., Ltd
  • 8.1.1. Company Overview
  • 8.1.2. Key Executives
  • 8.1.3. Company Snapshot
  • 8.1.4. Operating Business Segments
  • 8.1.5. Product Portfolio
  • 8.1.6. Business Performance
  • 8.1.7. Key Strategic Moves and Developments
• 8.2. TOSHIBA CORPORATION
  • 8.2.1. Company Overview
  • 8.2.2. Key Executives
  • 8.2.3. Company Snapshot
  • 8.2.4. Operating Business Segments
  • 8.2.5. Product Portfolio
  • 8.2.6. Business Performance
  • 8.2.7. Key Strategic Moves and Developments
• 8.3. Bio-Rad Laboratories Inc
  • 8.3.1. Company Overview
  • 8.3.2. Key Executives
  • 8.3.3. Company Snapshot
  • 8.3.4. Operating Business Segments
  • 8.3.5. Product Portfolio
  • 8.3.6. Business Performance
  • 8.3.7. Key Strategic Moves and Developments
• 8.4. Life Sign LLC
  • 8.4.1. Company Overview
  • 8.4.2. Key Executives
  • 8.4.3. Company Snapshot
  • 8.4.4. Operating Business Segments
  • 8.4.5. Product Portfolio
  • 8.4.6. Business Performance
  • 8.4.7. Key Strategic Moves and Developments
• 8.5. Schiller AG
  • 8.5.1. Company Overview
  • 8.5.2. Key Executives
  • 8.5.3. Company Snapshot
  • 8.5.4. Operating Business Segments
  • 8.5.5. Product Portfolio
  • 8.5.6. Business Performance
  • 8.5.7. Key Strategic Moves and Developments
• 8.6. Beckman Coulter, Inc.
  • 8.6.1. Company Overview
  • 8.6.2. Key Executives
  • 8.6.3. Company Snapshot
  • 8.6.4. Operating Business Segments
  • 8.6.5. Product Portfolio
  • 8.6.6. Business Performance
  • 8.6.7. Key Strategic Moves and Developments
• 8.7. GE Healthcare
  • 8.7.1. Company Overview
  • 8.7.2. Key Executives
  • 8.7.3. Company Snapshot
  • 8.7.4. Operating Business Segments
  • 8.7.5. Product Portfolio
  • 8.7.6. Business Performance
  • 8.7.7. Key Strategic Moves and Developments
• 8.8. Hitachi Medical Systems
  • 8.8.1. Company Overview
  • 8.8.2. Key Executives
  • 8.8.3. Company Snapshot
  • 8.8.4. Operating Business Segments
  • 8.8.5. Product Portfolio
  • 8.8.6. Business Performance
  • 8.8.7. Key Strategic Moves and Developments
• 8.9. F. Hoffmann-La Roche Ltd.
  • 8.9.1. Company Overview
  • 8.9.2. Key Executives
  • 8.9.3. Company Snapshot
  • 8.9.4. Operating Business Segments
  • 8.9.5. Product Portfolio
  • 8.9.6. Business Performance
  • 8.9.7. Key Strategic Moves and Developments
• 8.10. Abbott Laboratories
  • 8.10.1. Company Overview
  • 8.10.2. Key Executives
  • 8.10.3. Company Snapshot
  • 8.10.4. Operating Business Segments
  • 8.10.5. Product Portfolio
  • 8.10.6. Business Performance
  • 8.10.7. Key Strategic Moves and Developments

관련자료